AbCellera Biologics (ABCL) Debt Ratio (2020 - 2025)

AbCellera Biologics has reported Debt Ratio for 6 years, with the latest figure at 0.01 in Q1 2025.

• For the quarter ending Q1 2025, Debt Ratio fell 81.44% year-over-year to 0.01; the trailing twelve-month figure through Mar 2025 stood at 0.01 (down 81.44% YoY), and the FY2024 full-year result was 0.01, down 82.48% from the prior year.
• Debt Ratio for Q1 2025 stood at 0.01, up from 0.01 in the prior quarter.
• The five-year high for Debt Ratio was 0.04 in Q2 2023, with the low at 0.01 in Q4 2024.
• Historically, Debt Ratio has averaged 0.02 across 5 years, with a median of 0.02 in 2021.
• Annual changes were most pronounced in 2022 — Debt Ratio surged 113.92% — and 2024, when it slumped 82.48%.
• AbCellera Biologics' Debt Ratio stood at 0.02 in 2021, then jumped by 64.96% to 0.03 in 2022, then rose by 18.22% to 0.03 in 2023, then slumped by 82.48% to 0.01 in 2024, then climbed by 9.78% to 0.01 in 2025.
• The last three Debt Ratio figures came in at 0.01 (Q1 2025), 0.01 (Q4 2024), and 0.01 (Q3 2024), per Business Quant data.